Corium
Greg Bass currently serves as the Head of Market Access at Corium since January 2025. Prior to this role, Greg held the position of Executive Vice President, Global Market Access at Valinor Pharma from January 2023 to January 2025 and at Novos Growth Partners from January 2018 to January 2023. Earlier in the career, Greg was the Executive Vice President and Chief Commercial Officer at Lipocine Inc. from January 2015 to January 2018, and also served as Vice President, Market Access during that time. In 2014, Greg worked as Vice President, Managed Markets at Merz Therapeutics. Greg Bass earned a Bachelor’s Degree in Biology from Brandeis University.
This person is not in any teams
This person is not in any offices
Corium
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.